Application Sponsors
ANDA 209587 | NEXGEN PHARMA INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 325MG;50MG;40MG | 0 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-10-31 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
LGM PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 209587
[companyName] => LGM PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"325MG;50MG;40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/31\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"12\/28\/2018","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2018-12-28
)
)